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higher mean levels of each hormone by all assays (p<O.OOl for all). Results of all assays 
correlated closely (r values ranging between 0.902 and 0.975). The table shows the per- 
formance of optimal hormone values for diagnosis of HF (from receiver-operating-char- 
acteristic (ROC) analysis). In multivariate analysis hormones by any assay remained 
independently predictive of HF (p<O.OOl for all). Conclusions: BNP or N-BNP are useful 
in the diagnosis of HF in acutely dyspneic patients, providing additional power over clinl- 
cal and radiological data. Sensitivity was best with the Biosite BNP assay. Specificity and 
positive predictive value were greatest with N-BNP assays. 
1136-76 Pregnancy Associated Cardiomyopathy: Clinical Profile 
in 137 Patients Diagnosed in the United States 
Mohammed W. Akhter, Avraham Shotan. Afshan Hameed. Harpreet Singh, Salman 
Khan, Usman Ahsan. Muhammad T. Khan, Uri Elkayam, University of Southern 
California, Los Angeles, CA 
Background: Pregnancy associated cardiomyopathy (PACM) is an uncommon, but 
some times fatal form of heart failure. Because of the rarity of PACM and geographical 
differences in its presentation, the clinical profile of this condition has not been clearly 
defined. Methods: We reviewed records of 137 patients with PACM, either referred to 
our heart failure program or obtained by a national survey. Results: ClinIcal profile: Age- 
16-43 years (mean 30 * 6); Ethnic background-Caucasians 66%, Blacks 21%. Hispanics 
lo%, others 3%; Gravity-l-11 (mean 2.6 * 2.2); Index pregnancy-1st - 51%, 2nd - 20%, 
3rd - 20%, 4th - 12%, 5th or more - 17%; Duration of pregnancy-20-42 weeks (mean 36 
* 5); Mode of delivery-vaginal 50%. cesarean - 49%, abortion - 1%. Associated Condi- 
tions: There was a strong association between PACM and history of hypertension during 
pregnancy (56%), use of tocolytic therapy (29%) and twin pregnancy (31%) 
Left ventricular ejection fraction (LVEF): LVEF at time of diagnosis was 3Oi 12%. 43+ 
~ 15% at 6 months follow tip and 45+ 15% during last follow-up at an average of 26 
months. Normalization of LVEF (>50%) was observed in 54% of cases. This occured 
mostly within the 1st 6 months and was more likely in Caucasians, older patients (2 30 
1 
yrs), patients with gestational hypertension, and those with LVEF >30 % at diagnosis. 
Death. transplantatron and AICDs: Death was reported in 12 patients between delivery 
day and 9 years postpartum. 6 of these patients died suddenly. 5 patients had heart 
transplantation and 3 AICD implantation. Conclusion: 1. Pregnancy associated cardi- 
omyopathy in the US can occur at any age and in various ethnic groups. 2. PACM is 
related to 1st or 2nd pregnancy in almost 60% of cases. 3. There is a strong association 
between PACM and hypertension, use of tocolytic therapy and twin pregnancy. 4. Nor- 
malization of LVEF occurs in approximately half of the patients usually within first 6 
months postpartum. 5. Recovery of LV function is more likely in Caucasians, patients > 





1136-77 A Three-Month Weight Decrease Independently 
Predicted Increased Risk of Mortality and Heart Failure 
Hospitalization but Decreased Risk of Recurrent 
Myocardial Infarction in Patients With Acute Myocardial 
Infarction Complicated by Cardiac Failure 
Linn A. Kennedy, Margaret James, Ronnie Willenheimer, Malmo University Hospital, 
Malmo, Sweden 
Background: The prognostic impact of body weight and weight change has been little 
examined in patients after acute myocardial infarction (AMI). 
Methods: In 5477 patients with AMI and clinical signs of heart failure (HF) and/or systolic 
lefl ventricular dysfunction and/or anterior Q-waves, we assessed baseline body mass 
index (bBMI), weight change at 3 months (3-m WC), and several baseline variables com- 
prising demographics, patient history physical examination, laboratory values and medi- 
cation. Median follow-up from 3 months was around 1,000 days. Patients were 
categorized into four groups according to bBMI. 3-m WC was defined as WC (+/-) z-0.1 
kg/bBMI-unit. The value of 3-m WC lo predict total mortality, cardiac death, HF hospital- 
ization, and recurrent AMI was tested in uni- and multivariate Cox propoRional hazards 
models. 
Results: 4541 patients had complete 3-m WC data. During follow-up there were 503 
deaths, 318 cardiac deaths, 286 HF hospitalizations and 351 recurrent AMls. In univari- 
ate analysrs, relative to stable weight, 3-m decreasing weight was significantly predictive 
of death (HR 1.473, 95% Cl 1,210-l ,794. p<O.OOOl), cardiac death (HR 1.401, 1.093. 
1.797. p=O.OOE), and HF hospitalization (HR 1.459, 1.122-1.897. p=O.O05). However, 
decreasing weight was borderline significantly protective of recurrent AMI (HR 0.788, 
0,604-l ,028, p=O.O79). 
In multivariate analysis, stratified for bBMl.group, adjustment was done for baseline 
covariates including age, sex, smoking, blood pressure, pulse rate, S-glucose, S-creati- 
nine, cholesterol, triglycerides, hemoglobin, and history of diabetes, hypercholester- 
olemia, and AMI, and in-hospital treatment with aspirin, betablockers, diuretics, statins, 
and thrombolytics. Relative to stable weight, 3-m weight decrease was independently 
predictive of increased rusk of mortality (p=O.O236) and HF hospitalization (p=O.O373), but 
of decreased risk of recurrent AMI (p=O.O452). 
Conclusion: In a high risk post AMI population a 3-m body weight decrease was indepen- 
dently predictive of increased risk of all cause mortality and HF hospitalization, but inde- 
pendently predictive of decreased risk of recurrent AMI, in this multivariate model. 
1136-78 Brain Natriuretic Peptide and N-Terminal Brain 
Natriuretic Peptide in the Diagnosis of Heart Failure in 
Patients With Acute Shortness of Breath 
John G. Lainchbuq. Timothy G. Yandle, Elizabeth Campbell, Mark Richards, 
Christchurch School of Medicme and Health Sciences, Christchurch, New Zealand 
Background: Plasma brain natriuretic peptide (BNP) is useful in differentiating heart fail- 
ure (HF) from other causes of dyspnea. The N-terminal component (N-BNP) has a longer 
half-life, and increases in HF are proportionately greater. Methods: In 205 acutely dysp- 
neic patients we assessed the utility of BNP and N-BNP (and compared local and corn- 
mercial assays) for the diagnosis of HF. BNP was assayed with a point of care test 
(Biosite Diagnostics, California) and two locally developed radioimmunoassays, one 
(“clinical BNP”) has a shori incubation time for more rapid results than the other 
(“research BNP”). N-BNP was analysed with a local (“local N-BNP”) and a commercial 
assay (Roche Diagnostics, Germany). HF diagnosis was adjudicated by two cardiolo- 
gists using all information except hormone assays. Results: HF patients (n=70) had 
Optimal 
Value 
Sensi Speci Positive Negative Area Accuracy 
tivity ficity Predictive Predictive Under 
V&e Value ROC 
Curve 
Biosite 204pg/ml 94 70 82 
BNP 
96 0.88 78 
Clinical 44pmollL 88 82 69 
BNP 
94 0.89 84 
Resear 33pmoliL 87 82 71 
ch 
BNP 
92 0.90 83 
Roche 329pmol/L 82 87 76 
N-BNP 
90 0.89 85 
Local 238pmol/L 83 89 79 91 0.91 87 
N-BNP 
1136-79 Significance of Left Atrium Dimension and Pulmonary 
Veins Flow Parameters for the Detection of Severe 
Diastolic Dysfunction 
Karina A. Wierzbowska, Jaroslaw Drozdz, Maria Krzeminska-Pakula, Jaroslaw 
Kasprzak, Medical University of L6dz, Lcdz, Poland 
Background: Since the occurrence of pseudonormalization assessment of diastolic func- 
tion (DF) limited to mitral inflow pattern is often difficult. The routine incorporation of other 
classic echocardiographic parameters can be of great value for correct diagnosis. We 
aimed to compare left atrium (LA) dimension and pulmonary veins flow (PVF) between 
patients (pts) with normal and pseudonormal or restrictive mitral inflow pattern and 
assess their diagnostic value for detection of severely impaired DF. Methods: Among 60 
patient after myocardial infarction examined by transthoracic echocardiography with 
assessment of diastolic function we selected 20 pts with pseudonormal or restrictive 
mitral inflow pattern, (mean age 57.li11.9, 18 male) and compared them with demo- 
graphically paired controls (20 healthy persons, mean age 56.6*9.9, 18 male). PVF was 
recorded by pulsed wave Doppler in right upper pulmonary vein. Sensitivity, specificity, 
positive predictive value, negative predictive value and accuracy were calculated for 
LAb4.2 cm, atrial reversal velocity (Ar vel)>35 cm/s. difference between duration of PV 
atrial flow and mitral atrial flow (AA+30 ms and S/D ratio <I. Results: In group with 
severely impaired DF LA was distinctly larger: 4.7kO.4 vs 3.8kO.4 cm; p<O.OOl, diastolic 
PVF (D): 0.58iO.2 vs 0.43iO.l m/s; p =0.005, and atrial reversal duration (Art): 181*28 
vs 130+17 ms significantly greater, systolic PVF (S) and systolic to diastolic ratio (S/D) 
diminished: 0.37iO.l vs 0.58rO.l m/s; p<O.OOl and 0.7tO.3 vs 1.4+0.3; ~4.2 cm sensitiv- 
Ity, specificity, positive predictive value, negative predictive value and accuracy were: 95, 
90, 91, 95, 93% respectively. For Ar vel>35 cm/s, (A4At)>30 ms end S/D<1 these values 
were: 50,85,77,63.63%, 70,100,100,77,85% and 85, 85, 85, 85, 85% respectively. 
Conclusions: LA dimension and PVF parameters are useful in detection of severely 
impaired DF and may have potential in differentiation between normal and pseudonor- 
malized pattern. Cutoff values above 4.2 cm for LA, 35 cm/s for Ar vel, S/D below 1 and 
duration of Art longer than 30 ms in comparison with mitral atrial flow showed very high 
specificity for diagnosis of ?.evere diastolic dysfunction. 
1136-80 Long-Term Follow-Up on the Morbidity and Mortality of 
Patients Hospitalized for Heart Failure With a Normal 
Ejection Fraction 
Marc Klaoholz, Niklta Varshneya. El~ezer Hernandez, Radha Voletl, Sanjay Bhargava, 
Viiavasree Kudithirxrdi. .&heed Tai. Rakesh Gwta. Gunawardena Ratnasiri. Khashavar 
Sehiat, Morcos H&ah, John A. Ambrose, Joyce Burcham, Thierry LeJemtel, St. 
Vincent’s Catholic Medical Center, New York, NY 
Background: Patients hospitalized for heart failure (HF) with a normal left ventricular 
ejection fraction (LVEF) are predominantly elderly women with a history of hypertension, 
LVH, diabetes and coronary artery disease. The long term outcomes of these patients 
after hospitalization are less well defined. 
Methods: Patients hospitalized for decompensated HF as evidenced by pulmonary con- 
gestion on admitting chest xray and volume overload on physical exam in the presence 
of a normal LVEF were eligible. Patlents who survived the index admission were pro- 
spectively followed and data on recurrent hospitalization and death were collected. 
Results: 193 patients (139 women, 54 men) were followed for a mean of 1.8 years. The 
mean age was 71.7 years. 46% had coronary artery disease and 45% were diabetic. 
80% of patients had symptoms at baseline consistent with NYHA functional class 11-111 
(10% class I, 10% class IV). 64 deaths occurred with an annualized mortality of 18.2%. 
The annualized re-hospitalization rate was 79% (graph). 
Conclusion: Patients hospitalized for HF with a normal LVEF have significant long term 
morbidity and mortality. The mortality rate exceeds that generally reported in NYHA class 
II-ill systolic dysfunction HF patients and probably reflects the presence of significant co- 
morbidities in these patients Including advanced age. The annualized re-hospitalization 
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rates for HF (34%) is consistent with that generally reported in NYHA Class 11-111 systolic 
dvsfunction heart failure. 
1136-81 Evolution of Left Ventricular Filling Pattern Among 
American Indians: The Strong Heart Study 
Felizen S. Aano, Jennifer E. Liu, Marcello Chin&, Dawn Fishman, Jonathan N. Bella, 
James Galloway, Elisa T. Lee, Lyle Best, Richard B. Devereux, Weill Medical College of 
Cornell University, New York, NY 
Background: Relations of left ventricular (LV) diastolic filling patterns to hypertension and 
overweight have been extensively examined in cross-sectional studies but there are few 
data on long-term evolution of LV filling parameters in population-based samples. 
Methods: LV filling parameters were measured by Doppler echocardiography 7.2kO.7 
years apart in 247 American Indian participants (69% women, 58~7 years of age at base- 
line evaluation) in the population-based Strong Heart Study. 
Results: Between examtnations, there were no significant changes rn the systolic blood 
pressure (from 135+16 to 137*19mmHg, NS) and body mass index (both=32*6 kg/m’, 
NS). LV mass increased from 153e.36 to 168*36 g with decreases in LV fractional shorl- 
ening (35+5 to 33+ 6%, both p<OOOi) and LV midwall shortening (17.6Q.3 to 
17.1&3%, p=O.OOl). In parallel, there were decreases ln the peak E wave velocity 
(59-tl6 to 50+13 cm/?@ peak A wave velocity (71+16 to 66+14 cm/set) and the E/A 
ratio of transmttral flow (0.87+0.27 to 0.76r0.21, all pcO.001) accompanied by an 
increased prevalence of E/A ratio below a prognostically-validated partition value of 0.60 
(14 6% to 17.4%, p<O.O2). The decline between examinations in the mitral E/A ratio was 
related to older age at baseline evaluation (r=0.19, p=O.O02) and lesser decrease in ejec- 
bon fraction (r=-0.18, p=O.O07) but not to gender or change in body mass Index or sys- 
tollc pressure. In multiple regression analysis, the decline in mitral E/A ratio was greater 
with higher initial age (p=O.Ol) and less with decline in LV ejection fraction (p=O.O26) but 
was unrelated to temporal change in arterial pressure, LV mass, or body mass index. 
Conclusions: In a population-based sample of mtddle-aged and elderly adults, a 7-year 
follow-up of LV filling pattern among 247 American Indians participants showed that 
there was significant increase in the prevalence of transmitral E/A ratio below a prognos- 
tically-validated partition value. The decline between examinations in the mitral E/A ratio 
was related to older age at baseline evaluation and less with decline in ejection fraction 
and was unrelated to temporal change in arterial pressure, gender difference, LV mass, 
or body mass index 
1136-82 Evidence of Impaired Left Atrial Function Response to 
Exercise in Hypertrophic Cardiomyopathy Patients With 
Heart Failure 
Cinzia Cianfrocca, Francesco Pelliccia. Antonio Auriti, Furio Colivicchi, Antonino 
Granatelli, Giuseppe Richichi. Massimo Santlni. San Filippo Neri Hospital, Rome, Italy 
Background: Studies on determinants of symptoms of heart failure (HF) in pts with 
hypertrophic cardiomyopathy (HC) have focused mainly on LV systolic and/or diastolic 
dysfunction, whereas the pathophysiologic role of left atnal (LA) dynamics has been 
poorly investigated. To address this issue, we investigated the LA systolic function at rest 
and on exercise in a subset of HC pts with mild HF. 
Methods: Fifteen HC pts in NYHA class II (Gr.A; age: 47211 yrs) and 15 sax- and age- 
matched HC pts without symptoms of HF (Gr.6; age: 49_+12 yrs) were studied. All pts 
underwent, off-drug, a symptom-limited supine bicycle exercise test (25 watt/P mins). 
Doppler echocardiography was performed at baseline and at peak exercise. Indexes of 
LA morphology and function were derived from the apical 4. and P-chamber wws. 
Results: At baseline, the 2 groups exhibited similar LV morphology (i.e. maximal wall 
thickness and diameters), LV ejection fraction (55111 vs 63+9%, NS), and Doppler mea- 
sures of LV diastolic performance, i.e. E-peak (45217 vs 49119 cm/s, NS) and A-peak 
(66216 vs 61215 cm/s, NS). Also, they had similar LA maximal volume (7317 vs 71221 
cm3). LA stroke volume (11+8 vs 12+8 cd), and LA emptying fra& (l&9 vs 
25+10%). Exercise time was 441+220 s in Gr.A and 56e297 s in Gr.B. On exercise, LV 
ejection fraction did not change in Gr.A (-al 0%) but increased in Gr.B (+I &lo%, 
p<O.O5). No significant change with exercise in LA stroke volume (++6 ems) and LA 
emptying fraction (+&6) were seen in Gr.A. On the opposite, Gr.B showed an increase 
with exercise in LA stroke volume (+&8 ems, p&01), and LA emptying fraction 
(+15+10%, p<O.Ol). Comparison of Doppler indexes of LV filling in Gr.A showed no 
change with exercise in E-peak (-7~10 cm/s) and A-peak (+a10 cm/s). In Gr.B, con- 
versely, there were on exercise a slight increase in E-peak (+I9215 cm/s) and a signifi- 
cant augmentation in A-peak (+35+19 cm/s, p<O.Ol). 
Conclusion: Along with LV dynazc abnormalities, an impalred LA function response to 
exercise plays a pathophysiologic role in determining symptoms of mild HF in HC. These 
findings provide evidence that the LA myocardium is involved by the myopathic process 
in a subset of pts with HC. 
1136-83 100 Patients Supported for Over One Year on an 
Implanted Left Ventricular Assist Device 
R. Hetzer. R. Koerfer, M. Vigano, M. Pasque, R. Kormos, P. Partner, Tofv Mussivand on 
behalf of the Novacor LVAS Investigators, University of Ottawa Heart Institute. Ottawa, 
ON, Canada 
Background: The use of mechanical circulatory support (MCS) devices during the 
bridge to transplant experience can provide clinical insight into the potential use of these 
devices for long-term support or “Destination Therapy”. A review of the outcomes of first 
100 end-stage heart failure patients supported for greater than 1 year with an implanted 
left ventricular assist device (Novacor LVAS) was conducted. Methods: Utilizing data 
from the international registry, the patient characteristics and outcomes of 100 patients 
supported for > 1 year at 40 international centres were analyzed. Results: The patients 
ware 90% male with a mean age of 47 years (16-72 years). The disease etiology was 
cardiomyopathy in 63%, ischemic heart disease in 26% and other in 10%. The Intent to 
treat was as follows: 92% as a bridge to transplant. 4% as a bridge to recovery (Europe) 
and 4% as an alternative to transplant. Mean support duration on the device was 1.7 
years (370-1514 days) and 22 patients were supported over 2 years, 8 ovar 3 years and 
3 over 4 years. Outcomes were favorable (either ongoing, transplanted or weaned) for 
78% of patients. Subsequent analysis of patients supported over 6 months and I, 2, & 3 
years respectively, yielded similar outcomes at each time interval. There were no deaths 
related to device failure and the majority of patients were able to return home to near nor- 
mal activities.Conclusions: 1) A significant majority (78%) of these end-stage heart fail- 
ure patients had favorable outcomes and extension of life. 2) Improved quality of life was 
demonstrated with the majority of patients discharged from hospital. 3) Overall device 
safety has been demonstrated with no patient deaths due to device failure, and 4) Long- 
tern dewce durability has been demonstrated with patients supported for over 4 years on 
a single devce. These findings provide clear evidence that mechanical circulatory sup- 
port could potentially provide substantial clinical benefits during long-term support or 
“Destination Therapy”. 
* Due to space limitations only investigators with more than 5 patients supported over 1 
year are listed. 
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1137-62 Expanding the Donor Pool: Acceptable Recipient 
Outcomes With the Use of Hearts From Donors With 
Hepatitis B Core Antibody Positivity or Intracranial 
Tumors 
Sean P. Pinney Faisal H. Cheema, Kim Marie Hammond, Jonathan Chen, Niloo M. 
Edwards, Donna Mancini, Columbia University, New York, NY 
Background: The shortage of avallable donors limits cardiac transplantation. Transplan- 
tation of hearts from marginal donors could expand the donor pool if accompanied by 
good recipient outcomes. Donor hearts from patients with hepatitis B core antibodies 
(HBcAb) have not been used due to concern about virus transmission. Similarly, donors 
with malignant brain tumors have also been excluded. We conducted a retrospective 
review to determine the success of transplanting hearts from donors who were HBcAb+ 
or had an Intracranial tumor. Methods: We reviewed donor and recipient charts for 
patients transplanted at our center between January 1. 1997 and September I, 2002. 
Results: Of 514 hearl transplants performed in this time period, 46 (8.9%) used hearts 
from these marginal donors Fourteen patients (age 56+11 years) received hearts from 
donors with an intracranial tumor (age 4Ot9.6 years) Including 6 glioblastoma multiforme, 
2 anaplastic astrocytoma, 1 astrocytoma, 1 medulloblastoma. 1 pineal tumor. 1 meningi- 
oma and 2 not specified. At 23*10 months of follow-up, no patient had clinical or radio- 
logic evidence of tumor transmission. Thirty-two patients (age 46.9+18.7 years) received 
heatis from HBcAb+ donors (age 37.5*11 .O years). One patient (baseline HBSAg-) 
developed donor-transmitted HBV infection 10 months post-transplant that was success- 
fully treated with lamivudine. Two patients (baseline HBSAb-) had HBV seroconversion 
(HBSAb+) without evidence of HBV infection. Six patients were HBSAb+ pre-transplant 
and four patients (HBSAb-) received prophylactic lamivudine post-transplant. None of 
these patients developed donor-transmitted hepatitis; one lamivudine-treated patient 
